HUP0202534A3 - Fused pyrrolecarboxamides: gaba brain receptor ligands and pharmaceutical compositions containing them - Google Patents
Fused pyrrolecarboxamides: gaba brain receptor ligands and pharmaceutical compositions containing themInfo
- Publication number
- HUP0202534A3 HUP0202534A3 HU0202534A HUP0202534A HUP0202534A3 HU P0202534 A3 HUP0202534 A3 HU P0202534A3 HU 0202534 A HU0202534 A HU 0202534A HU P0202534 A HUP0202534 A HU P0202534A HU P0202534 A3 HUP0202534 A3 HU P0202534A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- receptor ligands
- brain receptor
- gaba brain
- Prior art date
Links
- RLOQBKJCOAXOLR-UHFFFAOYSA-N 1h-pyrrole-2-carboxamide Chemical class NC(=O)C1=CC=CN1 RLOQBKJCOAXOLR-UHFFFAOYSA-N 0.000 title 1
- 210000004556 brain Anatomy 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K51/047—Benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15178999P | 1999-08-31 | 1999-08-31 | |
| US38731199A | 1999-08-31 | 1999-08-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202534A2 HUP0202534A2 (hu) | 2002-11-28 |
| HUP0202534A3 true HUP0202534A3 (en) | 2002-12-28 |
Family
ID=26848974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202534A HUP0202534A3 (en) | 1999-08-31 | 2000-08-30 | Fused pyrrolecarboxamides: gaba brain receptor ligands and pharmaceutical compositions containing them |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7109351B1 (hu) |
| EP (1) | EP1210328A1 (hu) |
| JP (1) | JP2003508385A (hu) |
| KR (1) | KR20020027613A (hu) |
| CN (1) | CN1372546A (hu) |
| AP (1) | AP2002002420A0 (hu) |
| AU (1) | AU7092800A (hu) |
| BG (1) | BG106459A (hu) |
| BR (1) | BR0013664A (hu) |
| CA (1) | CA2381553A1 (hu) |
| CR (1) | CR6581A (hu) |
| CZ (1) | CZ2002614A3 (hu) |
| EA (1) | EA200200188A1 (hu) |
| EE (1) | EE200200111A (hu) |
| HR (1) | HRP20020104A2 (hu) |
| HU (1) | HUP0202534A3 (hu) |
| IL (1) | IL147971A0 (hu) |
| IS (1) | IS6290A (hu) |
| MX (1) | MXPA02001709A (hu) |
| NO (1) | NO20020948L (hu) |
| OA (1) | OA12015A (hu) |
| PL (1) | PL354513A1 (hu) |
| SK (1) | SK2582002A3 (hu) |
| TR (1) | TR200200544T2 (hu) |
| WO (1) | WO2001016103A1 (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050014939A1 (en) * | 1999-08-31 | 2005-01-20 | Neurogen Corporation | Fused pyrrolecarboxamides: GABA brain receptor ligands |
| AU2001241512A1 (en) * | 2000-03-13 | 2001-09-24 | Eli Lilly And Company | Sulfonamide derivatives |
| US6723332B2 (en) | 2000-05-26 | 2004-04-20 | Neurogen Corporation | Oxomidazopyridine-carboxamides |
| MXPA03001945A (es) * | 2000-09-06 | 2003-09-10 | Neurogen Corp | Tetrahidroindazoles sustituidos con arilo y su uso como ligandos para el receptor gaba-a. |
| WO2002020480A1 (en) * | 2000-09-06 | 2002-03-14 | Neurogen Corporation | Substituted fused pyrroleimines and pyrazoleimines |
| US6861529B2 (en) | 2001-07-06 | 2005-03-01 | Pfizer Inc | Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives |
| US6852730B2 (en) | 2002-02-07 | 2005-02-08 | Neurogen Corporation | Substituted fused pyrazolecarboxylic acid arylamides and related compounds |
| AU2004265189B2 (en) * | 2003-08-15 | 2010-03-04 | Banyu Pharmaceutical Co., Ltd. | Imidazopyridine derivatives |
| JP4964593B2 (ja) * | 2003-09-25 | 2012-07-04 | セノメド バイオサイエンシーズ，エルエルシー | 神経学的病状の治療用のテトラヒドロインドロン誘導体 |
| US7566781B2 (en) * | 2004-05-10 | 2009-07-28 | Banyu Pharmaceutical Co., Ltd. | Imidazopyridine compound |
| US20080275112A1 (en) * | 2004-07-23 | 2008-11-06 | Schreiner Peter R | Invention Concerning Aminoadamantane Compounds |
| MY150731A (en) * | 2006-11-27 | 2014-02-28 | Lundbeck & Co As H | Heteroaryl amide derivatives |
| JP2011506445A (ja) * | 2007-12-13 | 2011-03-03 | アムジエン・インコーポレーテツド | γ−セクレターゼ調節剤 |
| US8455477B2 (en) * | 2008-08-05 | 2013-06-04 | Merck Sharp & Dohme Corp. | Therapeutic compounds |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3455943A (en) | 1966-10-21 | 1969-07-15 | American Cyanamid Co | Certain 5,8-dihydro-beta-carbolines |
| US4075343A (en) | 1976-09-13 | 1978-02-21 | Pfizer Inc. | Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof |
| DE3029980A1 (de) | 1980-08-08 | 1982-03-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | Indolderivate und verfahren zu ihrer herstellung |
| JPS57123180A (en) | 1980-12-17 | 1982-07-31 | Schering Ag | 3-substituted beta-carboline, manufacture and psychotropic drug containing same |
| DE3147276A1 (de) | 1981-11-28 | 1983-06-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole |
| DE3246932A1 (de) | 1982-12-16 | 1984-06-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | Substituierte 5h-pyrimido(5,4-b)indole |
| DE3335323A1 (de) | 1983-09-27 | 1985-04-04 | Schering AG, 1000 Berlin und 4709 Bergkamen | Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| GB8429739D0 (en) | 1984-11-24 | 1985-01-03 | Fbc Ltd | Fungicides |
| DE3535927A1 (de) | 1985-10-04 | 1987-04-09 | Schering Ag | 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel |
| DK0552237T3 (da) | 1990-10-09 | 1993-07-28 | Neurogen Corp | Visse cycloalkyl- og azacycloalkyl-pyrrolopyrimidiner, en klasse af ligander for GABA-receptorer i hjernen |
| US5243049A (en) | 1992-01-22 | 1993-09-07 | Neurogen Corporation | Certain pyrroloquinolinones: a new class of GABA brain receptor ligands |
| EP0626966A1 (en) | 1992-02-19 | 1994-12-07 | PHARMACIA & UPJOHN COMPANY | 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity |
| US5266698A (en) | 1992-04-30 | 1993-11-30 | Neurogen Corporation | Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands |
| AU6098194A (en) | 1993-01-29 | 1994-08-15 | Ariad Pharmaceuticals, Inc. | Analogs of receptor tyrosine activation motifs and therapeutic uses thereof |
| US5750702A (en) * | 1993-10-27 | 1998-05-12 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands |
| US5484944A (en) | 1993-10-27 | 1996-01-16 | Neurogen Corporation | Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands |
| US6211365B1 (en) * | 1996-01-19 | 2001-04-03 | Neurogen Corporation | Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| US5804686A (en) * | 1996-01-19 | 1998-09-08 | Neurogen Corporation | fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| IT1287264B1 (it) * | 1996-03-21 | 1998-08-04 | Lino Crespan | Freno perfezionato per pattini con ruote in linea |
| US5955465A (en) | 1996-03-22 | 1999-09-21 | Neurogen Corporation | 1,2,4-triazolo 4,3-c!quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones |
| WO1997034870A1 (en) * | 1996-03-22 | 1997-09-25 | Neurogen Corporation | Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
| US5677309A (en) | 1996-03-22 | 1997-10-14 | Neurogen Corporation | 1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands |
| US5723462A (en) * | 1996-04-26 | 1998-03-03 | Neurogen Corporation | Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands |
| EA002243B1 (ru) * | 1997-11-13 | 2002-02-28 | Пфайзер Продактс Инк. | Способ синтеза пирроламидов |
-
2000
- 2000-08-30 EE EEP200200111A patent/EE200200111A/xx unknown
- 2000-08-30 WO PCT/US2000/023862 patent/WO2001016103A1/en not_active Application Discontinuation
- 2000-08-30 JP JP2001519673A patent/JP2003508385A/ja not_active Withdrawn
- 2000-08-30 CZ CZ2002614A patent/CZ2002614A3/cs unknown
- 2000-08-30 HU HU0202534A patent/HUP0202534A3/hu unknown
- 2000-08-30 CN CN00812233A patent/CN1372546A/zh active Pending
- 2000-08-30 OA OA1200200063A patent/OA12015A/en unknown
- 2000-08-30 CA CA002381553A patent/CA2381553A1/en not_active Abandoned
- 2000-08-30 AP APAP/P/2002/002420A patent/AP2002002420A0/en unknown
- 2000-08-30 EA EA200200188A patent/EA200200188A1/ru unknown
- 2000-08-30 BR BR0013664-6A patent/BR0013664A/pt not_active Application Discontinuation
- 2000-08-30 SK SK258-2002A patent/SK2582002A3/sk unknown
- 2000-08-30 TR TR2002/00544T patent/TR200200544T2/xx unknown
- 2000-08-30 IL IL14797100A patent/IL147971A0/xx unknown
- 2000-08-30 PL PL00354513A patent/PL354513A1/xx not_active Application Discontinuation
- 2000-08-30 EP EP00959643A patent/EP1210328A1/en not_active Withdrawn
- 2000-08-30 MX MXPA02001709A patent/MXPA02001709A/es active IP Right Grant
- 2000-08-30 KR KR1020027002757A patent/KR20020027613A/ko not_active Application Discontinuation
- 2000-08-30 AU AU70928/00A patent/AU7092800A/en not_active Abandoned
- 2000-08-30 US US09/651,207 patent/US7109351B1/en not_active Expired - Fee Related
-
2002
- 2002-02-01 HR HR20020104A patent/HRP20020104A2/hr not_active Application Discontinuation
- 2002-02-07 CR CR6581A patent/CR6581A/es not_active Application Discontinuation
- 2002-02-27 NO NO20020948A patent/NO20020948L/no unknown
- 2002-02-27 IS IS6290A patent/IS6290A/is unknown
- 2002-02-28 BG BG106459A patent/BG106459A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL147971A0 (en) | 2002-09-12 |
| CR6581A (es) | 2004-03-31 |
| WO2001016103A1 (en) | 2001-03-08 |
| MXPA02001709A (es) | 2002-10-23 |
| BR0013664A (pt) | 2002-05-14 |
| NO20020948D0 (no) | 2002-02-27 |
| EP1210328A1 (en) | 2002-06-05 |
| KR20020027613A (ko) | 2002-04-13 |
| SK2582002A3 (en) | 2003-02-04 |
| BG106459A (bg) | 2002-12-29 |
| IS6290A (is) | 2002-02-27 |
| HRP20020104A2 (en) | 2004-02-29 |
| CN1372546A (zh) | 2002-10-02 |
| EA200200188A1 (ru) | 2002-08-29 |
| CZ2002614A3 (cs) | 2002-08-14 |
| CA2381553A1 (en) | 2001-03-08 |
| TR200200544T2 (tr) | 2002-06-21 |
| NO20020948L (no) | 2002-02-28 |
| AU7092800A (en) | 2001-03-26 |
| JP2003508385A (ja) | 2003-03-04 |
| US7109351B1 (en) | 2006-09-19 |
| AP2002002420A0 (en) | 2002-03-31 |
| EE200200111A (et) | 2003-06-16 |
| OA12015A (en) | 2006-04-19 |
| HUP0202534A2 (hu) | 2002-11-28 |
| PL354513A1 (en) | 2004-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9800985A3 (en) | Retarde polymere compositions for pharmaceutical compositions | |
| HUP0201376A2 (en) | Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds | |
| CZ20011518A3 (cs) | Farmaceutický prostředek | |
| PL348112A1 (en) | Pharmaceutical moxifloxacin preparation | |
| HUP0203514A3 (en) | Quinuclidine compounds and drugs containing them and process for preparation the same | |
| HUP0100731A3 (en) | New oxazolidine-, thiazolidine-, pyrrolidine-and piperidin derivatives process for their preparation and pharmaceutical compositions containing them | |
| HUP0105108A3 (en) | Amide compounds, process for their preparation and pharmaceutical compositions containing them | |
| GB9706089D0 (en) | Pharmaceutical composition | |
| IL183972A0 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
| HUP0202534A3 (en) | Fused pyrrolecarboxamides: gaba brain receptor ligands and pharmaceutical compositions containing them | |
| HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| HUP0103340A2 (hu) | Kondenzált arilgyűrűt tarrtalmazó azapoliciklusos vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| IL133928A0 (en) | Pharmaceutical composition containing peptichemio | |
| GB9717444D0 (en) | Pharmaceutical composition | |
| ZA982073B (en) | Pharmaceutical preparation | |
| HUP0002455A3 (en) | Gastric-retained pharmaceutical composition | |
| GB9717428D0 (en) | Pharmaceutical composition | |
| IL122920A (en) | Castrointestinal drug composition | |
| HUP0002777A3 (en) | Fused thiazolobenzoheterocyclic derivatives, process for their preparation and pharmaceutical compositions containing same | |
| GB9717770D0 (en) | Pharmaceutical composition | |
| GB2321190B (en) | Pharmaceutical composition | |
| GB9726781D0 (en) | Pharmaceutical composition | |
| HUP0101012A3 (en) | Pharmaceutical composition for oral administration | |
| IL120319A0 (en) | Pharmaceutical preparation |